Jeremy Mudd
Papers
1
Total Citations
9
H-Index
1
About
Dr. Jeremy Mudd is a leading clinical researcher in thoracic oncology, with a focused expertise in patient-centered outcomes for early-stage lung cancer. His work bridges the critical gap between oncologic efficacy and quality of life, particularly for patients who are not candidates for traditional lobectomy. Dr. Mudd’s most cited study, “Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early‐stage non–small cell lung cancer,” is a landmark investigation that provides essential, real-world data on how these two common treatments—sublobar resection and SBRT—affect patients’ physical, emotional, and social well-being over time. By prioritizing the patient’s lived experience, this work has already garnered significant attention (9 citations in its first year) and is shaping clinical decision-making for a vulnerable population. Dr. Mudd’s contributions are vital for moving beyond survival statistics, ensuring that treatment choices are informed by the outcomes that matter most to patients. His research is a cornerstone for developing more compassionate, individualized care pathways in thoracic surgery and radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1